Dual Luciferase Reporter Gene System: Mechanisms & Benchmark
2026-05-15
The Dual Luciferase Reporter Gene System enables sensitive, normalized quantification of gene expression regulation in mammalian cells. This system uses independent firefly and Renilla luciferase reactions for robust, high-throughput bioluminescence reporter assays. APExBIO’s K1136 kit streamlines workflows, supports direct reagent addition, and offers proven compatibility with multiple media.
Berberrubine chloride: Multi-Target Mechanisms & Research Pr
2026-05-15
Berberrubine chloride is a DMSO-soluble, multi-target isoquinoline alkaloid for scientific research. It demonstrates selective inhibition of IMPDH2 and TrxR, potent anti-colorectal and anti-NSCLC activity, and protocol-driven efficacy in metabolic and cancer models.
HRP Rabbit Anti-Goat IgG (H+L) Antibody: Precision in Immuno
2026-05-14
Unlock robust, low-background detection of goat antibodies in ELISA, western blot, and immunohistochemistry using the HRP Rabbit Anti-Goat IgG (H+L) Antibody from APExBIO. This guide bridges cutting-edge findings from pulmonary toxicology with actionable protocol enhancements and troubleshooting for optimal assay performance.
Prevotella copri Drives Breast Cancer via IPA Depletion
2026-05-14
This study uncovers a direct mechanistic link between gut Prevotella copri colonization and breast cancer progression, mediated by the depletion of host indole-3-pyruvic acid (IPA) and subsequent inactivation of the AMPK pathway via UHRF1. The findings highlight IPA as an intrinsic anti-cancer metabolite and suggest new avenues for microbiome-metabolite-targeted interventions in oncology.
RITA (NSC 652287): Redefining Precision in Renal Carcinoma R
2026-05-13
Discover how RITA (NSC 652287) drives precision in renal carcinoma research through selective p53 activation and advanced in vitro/in vivo models. This article uniquely explores practical assay design, protocol optimization, and nuanced viability analysis.
L-NMMA Acetate: Benchmarking a NOS Pathway Inhibitor in Rese
2026-05-13
L-NMMA acetate is a validated, high-purity inhibitor of all three nitric oxide synthase isoforms. This article details its biological rationale, mechanism, and experimental parameters, supporting its use in nitric oxide pathway modulation within inflammation and regenerative research. Evidence is provided from both peer-reviewed literature and product-specific documentation.
Anlotinib for IADSRCT: Case Evidence and Research Perspectiv
2026-05-12
This article reviews the first documented case of intra-abdominal desmoplastic small round cell tumor (IADSRCT) effectively managed with anlotinib, a multi-target tyrosine kinase inhibitor. The findings highlight anlotinib's promise in rare, treatment-resistant tumors, and provide mechanistic and methodological insights for researchers in cancer biology.
Talabostat Mesylate (PT-100): Applied Protocols in Tumor Imm
2026-05-12
Talabostat mesylate (PT-100) reshapes tumor microenvironment research by targeting DPP4 and FAP, offering a mechanistic bridge from T-cell inflammasome biology to cancer modeling. This article distills actionable workflows, protocol optimizations, and key troubleshooting strategies for leveraging Talabostat in cutting-edge immune modulation and oncology studies.
RP3-340N1.2 Knockdown Impairs NSCLC via IL-6 mRNA Destabiliz
2026-05-11
This study identifies the lncRNA RP3-340N1.2 as a critical driver of non-small cell lung cancer (NSCLC) progression by stabilizing IL-6 mRNA. Knockdown of RP3-340N1.2 not only suppresses tumor cell proliferation and migration but also enhances IL-6 mRNA degradation by promoting ZC3H12A binding, highlighting a promising lncRNA target for future transcriptional regulation research.
BH3 Mimetics Target Chemotherapy-Induced Senescence in TP53
2026-05-11
This study demonstrates that BH3 mimetics selectively eliminate senescent tumor cells after chemotherapy in TP53 wild-type breast cancer. By overcoming the survival advantage of senescent cells, this approach enhances tumor regression and may improve patient outcomes.
Oligo (dT) 25 Beads: Technical Guide for Eukaryotic mRNA Iso
2026-05-10
Oligo (dT) 25 Beads provide a streamlined, magnetic bead-based method for isolating polyadenylated mRNA from eukaryotic samples, enabling efficient downstream applications such as cDNA synthesis and RT-PCR. Use is limited to polyA tail-containing transcripts and is unsuitable for prokaryotic or non-polyadenylated RNA.
TCAIM Modulates Mitochondrial OGDH Levels to Control Metabol
2026-05-09
Wang et al. (2025) identify TCAIM as a mitochondrial DNAJC co-chaperone that specifically binds and reduces α-ketoglutarate dehydrogenase (OGDH) protein levels, introducing a novel post-translational regulatory mechanism for mitochondrial metabolism. This finding advances understanding of mitochondrial proteostasis and opens new avenues for metabolic research and targeted intervention.
ATRA Reverses Cisplatin-Induced PARP Inhibitor Resistance in
2026-05-09
This study demonstrates that all-trans retinoic acid (ATRA) effectively sensitizes cisplatin-exposed epithelial ovarian cancer (EOC) cells to PARP inhibition, addressing a key mechanism of drug resistance. The findings reveal that ATRA downregulates resistance-associated genes and NAD+ levels, proposing a rational combination maintenance strategy for EOC therapy.
ABT-737 in Cancer Research: Precision BCL-2 Inhibition Explo
2026-05-08
Explore how ABT-737, a leading BCL-2 protein inhibitor, revolutionizes apoptosis induction in cancer cells. This article uniquely bridges advanced in vitro assay design with practical insights for translational oncology.
Annexin V-Cy5/DAPI Apoptosis Kit: Precision in Mitochondrial
2026-05-07
Explore how the Annexin V-Cy5/DAPI Apoptosis Kit enables precise, rapid apoptosis detection with advanced insight into mitochondrial pathways. This in-depth article connects the latest leukemia research with practical assay optimization, setting a new benchmark for apoptosis detection kits.
466 records 19/32 page Previous Next First page 上5页 1617181920 下5页 Last page